ATP-binding cassette (ABC) transporters in human metabolism and diseases

被引:121
作者
Stefková, J [1 ]
Poledne, R [1 ]
Hubácek, JA [1 ]
机构
[1] Ctr Expt Cardiovasc Res, Inst Clin & Expt Med, Lab Atherosclerosis Res, Prague, Czech Republic
关键词
ABC transporter; lipid metabolism; cholesterol; mutation;
D O I
10.33549/physiolres.930432
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The ATP-binding cassette (ABC) superfamily of active transporters involves a large number of functionally diverse transmembrane proteins. They transport a variety of substrates including amino acids, lipids, inorganic ions, peptides, saccharides, metals, drugs, and proteins. The ABC transporters not only move a variety of substrates into and out of the cell, but also are also involved in intracellular compartmental transport. Energy derived from the hydrolysis of ATP is used to transport the substrate across the membrane against a concentration gradient. The typical ABC transporter consists of two transmembrane domains and two nucleotide-binding domains. Defects in 14 of these transporters cause 13 genetic diseases (cystic fibrosis, Stargardt disease, adrenoleukodystrophy, Tangier disease, etc.). Mutations in three genes affect lipid levels expressively. Mutations in ABCA1 cause severe HDL deficiency syndromes called Tangier disease and familial high-density lipoprotein deficiency, which are characterized by a severe deficiency or absence of high-density lipoprotein in the plasma. Two other ABCG transporters, ABCG5 and ABCG8, mutations of which cause sitosterolemia, have been identified. The affected individuals absorb and retain plant sterols, as well as shellfish sterols.
引用
收藏
页码:235 / 243
页数:9
相关论文
共 59 条
[2]  
Assmann G, 1995, METABOLIC MOL BASES, P2053
[3]   The photoreceptor rim protein is an ABC transporter encoded by the gene for recessive Stargardt's disease (ABCR) [J].
Azarian, SM ;
Travis, GH .
FEBS LETTERS, 1997, 409 (02) :247-252
[4]  
Berge KE, 2002, J LIPID RES, V43, P486
[5]   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[6]   A family of drug transporters: The multidrug resistance-associated proteins [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302
[7]   Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [J].
Brooks-Wilson, A ;
Marcil, M ;
Clee, SM ;
Zhang, LH ;
Roomp, K ;
van Dam, M ;
Yu, L ;
Brewer, C ;
Collins, JA ;
Molhuizen, HOF ;
Loubser, O ;
Ouelette, BFF ;
Fichter, K ;
Ashbourne-Excoffon, KJD ;
Sensen, CW ;
Scherer, S ;
Mott, S ;
Denis, M ;
Martindale, D ;
Frohlich, J ;
Morgan, K ;
Koop, B ;
Pimstone, S ;
Kastelein, JJP ;
Genest, J ;
Hayden, MR .
NATURE GENETICS, 1999, 22 (04) :336-345
[8]   Isolation and characterization of a mammalian homolog of the Drosophila white gene [J].
Croop, JM ;
Tiller, GE ;
Fletcher, JA ;
Lux, ML ;
Raab, E ;
Goldenson, D ;
Son, D ;
Arciniegas, S ;
Wu, RL .
GENE, 1997, 185 (01) :77-85
[9]   Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis [J].
De Vree, JML ;
Jacquemin, E ;
Sturm, E ;
Cresteil, D ;
Bosma, PJ ;
Aten, J ;
Deleuze, JF ;
Desrochers, M ;
Burdelski, M ;
Bernard, O ;
Elferink, RPJO ;
Hadchouel, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :282-287
[10]   EVOLUTION OF ATP-BINDING CASSETTE TRANSPORTER GENES [J].
DEAN, M ;
ALLIKMETS, R .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1995, 5 (06) :779-785